AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (421.1 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Original Article | Open Access

Evaluation of the multiple HPV-based “screen and triage” algorithms in real-world settings of rural China

Remila Rezhake1,2Guzhanuer Abuduxikuer1Guligeina Abudurexiti1,2Qian Zhuo1Kadeliya Muhetaer1Tangnuer Abulimiti1Yumei Ouyang1Wenyun Li1Jing Yang1Gulixian Tuerxun1Fanghui Zhao3Guzhalinuer Abulizi1,2 ( )Marc Arbyn4,5
Xinjiang Cancer Center, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830000, China
Xinjiang Key Laboratory of Oncology, Affiliated Cancer Hospital of Xinjiang Medical University, Urumqi 830000, China
Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Unit Cancer Epidemiology, Belgian Cancer Centre, Sciensano, Brussels 1050, Belgium
Department of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent 9000, Belgium
Show Author Information

Abstract

Objective

Drawbacks of human papillomavirus (HPV) primary screening, including high referral rates and low specificity, highlight the necessity for triage strategies to balance the screening benefits with potential harms.

Methods

A cross-sectional, population-based diagnostic study was conducted in rural Xinjiang, China involving 8,638 women ≥ 25 years of age who participated in organized cervical cancer screening between 2023 and 2024. The study evaluated the accuracy and efficiency of multiple HPV-based “screen-triage” strategies. Histologically confirmed cervical intraepithelial neoplasia grade 2 or worse (CIN2+ and CIN3+) served as disease outcomes.

Results

Among single-step triage strategies, only extended genotyping for the seven most carcinogenic HPV types (HPV16/18/31/33/45/52/58) maintained sensitivity for CIN2+ comparable to HPV screening without triage (90.0% vs. 92.5%, P = 0.50) but significantly improved specificity (94.7% vs. 90.8%, P < 0.001). This approach led to a 38% reduction in colposcopy referrals (relative rate, 0.62; 95% CI: 0.59–0.65). Two-step triage algorithms (HPV16/18 with reflex ASC-US+ or methylation) showed slightly lower but non-significant sensitivity (87.5%, P = 0.13/89.6%, P =0.50) than HPV primary screening without triage, yet achieved significantly increased specificity (> 95%, P < 0.001) and reduced colposcopy referral by ~50% (relative rate, 0.5; P < 0.001). If negative for cytology or methylation, women positive for 12 high-risk HPV types (excluding HPV16/18) had a < 2% risk of CIN2+ (CIN3+ risk < 1%), indicating delayed follow-up.

Conclusions

Focusing on the seven high-risk HPV types within a one-step “screen-triage” framework effectively balances minimal sensitivity loss with significant gains in specificity, reducing unnecessary referrals and treatments, especially valuable in resource-limited settings. Integrating HPV genotyping with methylation results improves the accurate identification of women requiring immediate referral, which is advisable when resources allow.

Electronic Supplementary Material

Download File(s)
cbm-22-9-1053-ESM.pdf (143.8 KB)

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 1053-1067

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Rezhake R, Abuduxikuer G, Abudurexiti G, et al. Evaluation of the multiple HPV-based “screen and triage” algorithms in real-world settings of rural China. Cancer Biology & Medicine, 2025, 22(9): 1053-1067. https://doi.org/10.20892/j.issn.2095-3941.2025.0384

268

Views

28

Downloads

2

Crossref

3

Web of Science

2

Scopus

Received: 15 July 2025
Accepted: 08 September 2025
Published: 01 September 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial4.0 International License